High-Flow Nasal Cannula Oxygen in Adults: An Evidence-based Assessment.
Drake MG.
Ann Am Thorac Soc. 2018 Feb;15(2):145-155. doi: 10.1513/AnnalsATS.201707-548FR.
AARC Clinical Practice Guideline: Management of Adult Patients With Oxygen in the Acute Care Setting.
Piraino T, Madden M, Roberts KJ, Lamberti J, Ginier E, Strickland SL.
Respir Care. 2022 Jan;67(1):115-128. doi: 10.4187/respcare.09294. Epub 2021 Nov 2.
High-flow nasal cannula therapy, factors affecting effective inspired oxygen fraction: an experimental adult bench model.
Duprez F, de Terwangne C, Bellemans V, Poncin W, Reychler G, Sorgente A, Cuvelier G, Mashayekhi S, Wittebole X.
J Clin Monit Comput. 2022 Oct;36(5):1441-1448. doi: 10.1007/s10877-021-00784-z. Epub 2021 Dec 8.
Time-Efficient Inspiratory Muscle Strength Training Lowers Blood Pressure and Improves Endothelial Function, NO Bioavailability, and Oxidative Stress in Midlife/Older Adults With Above-Normal Blood Pressure.
Craighead DH, Heinbockel TC, Freeberg KA, Rossman MJ, Jackman RA, Jankowski LR, Hamilton MN, Ziemba BP, Reisz JA, D'Alessandro A, Brewster LM, DeSouza CA, You Z, Chonchol M, Bailey EF, Seals DR.
J Am Heart Assoc. 2021 Jul 6;10(13):e020980. doi: 10.1161/JAHA.121.020980. Epub 2021 Jun 29.
High-Flow and Low-Flow Oxygen Delivery by Nasal Cannula Evaluated in Infant and Adult Airway Replicas.
Sabz M, Noga ML, Finlay WH, Rouhani H, Martin AR.
Respir Care. 2024 Mar 27;69(4):438-448. doi: 10.4187/respcare.11438.
Ratio of Oxygen Saturation to Inspired Oxygen, ROX Index, Modified ROX Index to Predict High Flow Cannula Success in COVID-19 Patients: Multicenter Validation Study.
Ruangsomboon O, Jirathanavichai S, Phanprasert N, Puchongmart C, Boonmee P, Thirawattanasoot N, Dorongthom T, Monsomboon A, Praphruetkit N.
West J Emerg Med. 2023 Apr 28;24(3):511-521. doi: 10.5811/westjem.58311.
Humidity and Inspired Oxygen Concentration During High-Flow Nasal Cannula Therapy in Neonatal and Infant Lung Models.
Chikata Y, Ohnishi S, Nishimura M.
Respir Care. 2017 May;62(5):532-537. doi: 10.4187/respcare.05319. Epub 2017 Feb 7.
[High-flow nasal oxygen in acute hypoxemic respiratory failure].
Rodriguez M, Arrivé F, Thille AW, Frat JP.
Rev Mal Respir. 2022 Sep;39(7):607-617. doi: 10.1016/j.rmr.2022.06.001. Epub 2022 Jul 30.
Simultaneous reduction of flow and fraction of inspired oxygen (FiO(2)) versus reduction of flow first or FiO(2) first in patients ready to be weaned from high-flow nasal cannula oxygen therapy: study protocol for a randomized controlled trial (SLOWH trial).
Kim MC, Lee YJ, Park JS, Cho YJ, Yoon HI, Lee CT, Lee JH, Kim ES.
Trials. 2020 Jan 14;21(1):81. doi: 10.1186/s13063-019-4019-7.
Velocity-based target flow rate for high-flow nasal cannula oxygen therapy.
Kusubae R, Hirabayashi M, Nakazaki N, Shinkoda Y.
Pediatr Int. 2021 Jul;63(7):770-774. doi: 10.1111/ped.14545. Epub 2021 Jun 8.
